IL159494A0 - 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity - Google Patents

6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity

Info

Publication number
IL159494A0
IL159494A0 IL15949402A IL15949402A IL159494A0 IL 159494 A0 IL159494 A0 IL 159494A0 IL 15949402 A IL15949402 A IL 15949402A IL 15949402 A IL15949402 A IL 15949402A IL 159494 A0 IL159494 A0 IL 159494A0
Authority
IL
Israel
Prior art keywords
phosphonomethoxy
antiviral activity
pyrimidine derivatives
alkoxy pyrimidine
alkoxy
Prior art date
Application number
IL15949402A
Other languages
English (en)
Original Assignee
Acad Of Science Czech Republic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic filed Critical Acad Of Science Czech Republic
Publication of IL159494A0 publication Critical patent/IL159494A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15949402A 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity IL159494A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30221201P 2001-06-29 2001-06-29
PCT/CZ2002/000038 WO2003002580A1 (fr) 2001-06-29 2002-06-28 Nouveaux composes et methodes therapeutiques

Publications (1)

Publication Number Publication Date
IL159494A0 true IL159494A0 (en) 2004-06-01

Family

ID=23166777

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15949402A IL159494A0 (en) 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Country Status (21)

Country Link
US (2) US6818633B2 (fr)
EP (1) EP1406911B1 (fr)
JP (1) JP4545434B2 (fr)
KR (1) KR100891366B1 (fr)
CN (1) CN1329404C (fr)
AP (1) AP1622A (fr)
AU (1) AU2002315625B2 (fr)
BR (1) BRPI0210746B8 (fr)
CA (1) CA2452036C (fr)
CZ (1) CZ297267B6 (fr)
EA (1) EA006020B1 (fr)
ES (1) ES2564144T3 (fr)
HU (1) HU230519B1 (fr)
IL (2) IL159494A0 (fr)
MX (1) MXPA04000138A (fr)
NO (2) NO333788B1 (fr)
NZ (1) NZ530685A (fr)
PL (1) PL207187B1 (fr)
TR (1) TR200302288T2 (fr)
WO (1) WO2003002580A1 (fr)
ZA (1) ZA200400236B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102815B1 (ko) * 2003-06-16 2012-01-05 케이.유.루벤 리서치 앤드 디벨럽먼트 항바이러스 뉴클레오티드 유사체인 포스포네이트기를 갖는 피리미딘 화합물
US20060211650A1 (en) * 2004-12-16 2006-09-21 Forest Laboratories, Inc. Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
ES2401285T3 (es) 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
AU2006272521A1 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of HIV
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
US20080318986A1 (en) * 2005-10-13 2008-12-25 Schiffman Rhett M Ddc Compositions
FR2908133B1 (fr) * 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
EP2707004A1 (fr) * 2011-05-10 2014-03-19 Okapi Sciences NV Composés destinés à être utilisés dans le traitement d'infections rétrovirales chez les félins
ES2687958T3 (es) 2013-03-15 2018-10-30 The Regents Of The University Of California Fosfonato diésteres de nucleósido acíclico
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
SG11201701957XA (en) 2014-09-15 2017-04-27 Univ California Nucleotide analogs
EP3350191B9 (fr) 2015-09-15 2021-12-22 The Regents of the University of California Analogues nucléotidiques
WO2019206907A1 (fr) * 2018-04-23 2019-10-31 Centre National De La Recherche Scientifique Nouveaux analogues d'acyclonucléosides antiviraux

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
CA2001715C (fr) 1988-11-14 1999-12-28 Muzammil M. Mansuri Nucleosides et nucleotides carbocycliques
CA2479846C (fr) 1989-05-15 2007-07-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Scienc Es Of The Czech Republic Derives de phosphonomethoxymethylpurine/pyrimidine
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
CZ285420B6 (cs) 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
US5356886A (en) 1990-07-19 1994-10-18 Beecham Group P.L.C. Antiviral phosphono-alken derivatives of purines
EP0468119A1 (fr) 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Nouveaux analogues carbocycliques de certains nucléosides
DK0481214T3 (da) 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
US5208221A (en) 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
CZ284678B6 (cs) 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
EP0531597A1 (fr) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Dérivés acycliques insaturés d'acides phosphoniques puriniques ou pyrimidimiques
JP3497505B2 (ja) 1991-10-11 2004-02-16 インスティテュート オブ オルガニック ケミストリー アンド バイオケミストリー オブ ザ アカデミー オブ サイエンシズ オブ ザ チェコ パブリック 抗ウイルス性非環式ホスホノメトキシアルキル置換アルケニル及びアルキニルプリン及びピリミジン誘導体
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
EP0618214A1 (fr) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Dérivés phosphonates insaturés de purines et de pyrimidines
JP4086314B2 (ja) 1993-09-17 2008-05-14 ギリアード サイエンシーズ, インコーポレイテッド ヌクレオチドアナログ
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use

Also Published As

Publication number Publication date
HUP0400345A3 (en) 2007-05-29
US6818633B2 (en) 2004-11-16
HU230519B1 (hu) 2016-10-28
CZ297267B6 (cs) 2006-10-11
TR200302288T2 (tr) 2004-12-21
EP1406911A1 (fr) 2004-04-14
BRPI0210746B8 (pt) 2021-05-25
EP1406911B1 (fr) 2016-01-06
CN1533397A (zh) 2004-09-29
IL159494A (en) 2008-06-05
CN1329404C (zh) 2007-08-01
BRPI0210746A8 (pt) 2018-07-10
KR20040027521A (ko) 2004-04-01
BRPI0210746B1 (pt) 2018-09-18
EA200400117A1 (ru) 2004-08-26
MXPA04000138A (es) 2005-06-06
ZA200400236B (en) 2004-08-18
KR100891366B1 (ko) 2009-04-02
AP2004002953A0 (en) 2004-03-31
WO2003002580A8 (fr) 2003-01-30
ES2564144T3 (es) 2016-03-18
PL366852A1 (en) 2005-02-07
JP4545434B2 (ja) 2010-09-15
US20030109499A1 (en) 2003-06-12
NO20035797L (no) 2004-02-24
NO20131091L (no) 2004-02-24
AU2002315625B2 (en) 2008-05-01
JP2005511490A (ja) 2005-04-28
CA2452036A1 (fr) 2003-01-09
PL207187B1 (pl) 2010-11-30
EA006020B1 (ru) 2005-08-25
HUP0400345A2 (hu) 2004-09-28
AP1622A (en) 2006-06-16
CA2452036C (fr) 2009-09-29
WO2003002580A1 (fr) 2003-01-09
CZ2004142A3 (cs) 2004-05-12
NO335725B1 (no) 2015-02-02
BR0210746A (pt) 2004-07-20
NZ530685A (en) 2006-09-29
NO333788B1 (no) 2013-09-16
US20050038058A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
HUS2200038I1 (hu) HIV-gátló pirimidinszármazékok
HK1062300A1 (en) 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d)pyrimidine derivatives
DK1416935T3 (da) 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater
GB0112617D0 (en) Antiviral nucleoside derivatives
HUP0402171A3 (en) Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
IL153754A0 (en) Pyrimidine derivatives
HK1070071A1 (en) New pyrimidine compounds
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
EP1458687A4 (fr) Composes de pyrimidine
IL159494A0 (en) 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
HK1078079A1 (en) Pyrimidine derivatives
EP1406619A4 (fr) Derives de guanidine ou de biguanidine antiviraux et antimicrobiens
AU2002362806A1 (en) Pyrimidine derivatives
GB0112803D0 (en) Pyrimidine derivatives
PL373334A1 (en) 4"-deoxy-4"-(s)-amido avermectin derivatives
AU2002352782A8 (en) Antitumor activity of bok
GB0119477D0 (en) Pyrimidine derivatives
GB0119475D0 (en) Pyrimidine derivatives
GB0112809D0 (en) Pyrimidine derivatives
GB0112805D0 (en) Pyrimidine derivatives
GB0112807D0 (en) Pyrimidine derivatives
GB0112808D0 (en) Pyrimidine derivatives
GB0112804D0 (en) Pyrimidine derivatives
GB0130695D0 (en) Pyrazola[4,3]pyrimidine
SI1446399T1 (en) Piperazine derivatives having sst1 antagonistic activity

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted